Clearmind Medicine's CMND-100 meets primary endpoint in phase trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. SPY
2. USO
3. ORCL
4. SPCX
5. NET
6. CHWY
7. SJM
8. SAIL
9. MU
10. AMZN

Go back to Clearmind Medicine's CMND-100 meets primary endpoint in phase trial
(NASDAQ: CMND) Delayed: 3.20 --0 (-0%)
Previous Close $3.20    52 Week High $ 
Open $3.20    52 Week Low $ 
Day High $3.20    P/E N/A 
Day Low $3.20    EPS $ 
Volume 17,184